Position in DXCM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$823,084
+$580,676 QoQ
Shares Held
12,221
+216.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#503
of 966 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Howard Capital Management Inc. holds $5,011,196 across 7 Medical Devices names. DXCM ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,692 | $1,151,672 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
13,764 | $881,033 | |
| 3 | DXCM |
Dexcom Inc
This page
|
12,221 | $823,084 | |
| 4 | SYK |
Stryker Corp
|
2,417 | $760,968 | |
| 5 | MDT |
Medtronic plc
|
8,981 | $702,583 | |
| 6 | BSX |
Boston Scientific Corp
|
9,074 | $387,278 | |
| 7 | EW |
Edwards Lifesciences Corp
|
3,367 | $304,578 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $823,084 | 12,221 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $242,408 | 3,860 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $605,825 | 9,128 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $600,361 | 8,922 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $779,848 | 8,934 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $646,569 | 9,468 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $849,326 | 10,921 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $710,892 | 10,604 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||